CANCER: Erlotinib-bevacizumab combo beats bevacizumab alone CANCER: Mortality rate spike seen in smokers on HRT comboEight-year study finds 61% greater likelihood of death from NSCLC CANCER: Pemetrexed boosts non-small cell survival rates Patients with nonsquamous cell carcinoma live up to 5.2 months longer, research shows CANCER: Second-line chemotherapy patients benefit from vandetanib Drop of 21% in risk of disease progression seen after 13-month followup Income gap in Ontario cancer screening Low rate of follow-up care to abnormal Pap tests Annual screening for skin cancer: Reasons for non-compliance Breast cancer testing to restart Ovary removal linked to higher risk of lung cancer Canadian researcher says result is preliminary, but intriguing Ovarian Cancer Helping patients navigate treatment courses and manage side effects CANCER: Anal cancer gold standard remains best approach Chemo should be standard approach for metastatic colorectal cancer 93% of patients had no future complications with chemo CANCER: Drug may reduce distant metastases in rectal cancer First Previous 68 69 70 71 72 Next Last
